Pharmaceuticals

GLP-1 Therapy Significantly Increases Visceral Adipose Tissue Metabolic Activity in Patients with Obesity, Obstructive Sleep Apnea

bexib
By bexib 0 Min Read

Findings from a study published in the Journal of the Obesity Society may significantly advance the understanding of GLP-1 analogues and their role in treating obesity.

You Might Also Like

FDA approval is just the beginning: Now Lilly’s Kisunla faces a tough Alzheimer’s market.

Researchers identify link between periodontal disease and early-onset stroke

The Royal Marsden opens UK’s first genomic testing facility to improve cancer testing

Despite admissions committee rejection, Lycos CEO sees potential for MDMA drug

FDA Accepts Supplemental New Drug Application from Otsuka and Lundbeck for Brexpiprazole Treatment for Adults with Post-Traumatic Stress Disorder

Share This Article
Previous Article Synthetic Lethality: Q&A with Oren Gilad, CEO of Aprea Therapeutics
Next Article Southeast Asia’s solar surge shows how dynamic trade execution must be
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

In preparation. Introducing a week-long culinary collaboration to raise money for children’s food education
Hospitality & Tourism
Listen: Top 3 Bank Automation News Podcasts of 2024
Banking
What is precision agriculture and how does it work?
Agro Businesses
Opening Facebook shop in 2025
Retail & E-commerce